Custom MHC Class II HLA-DP Xynapse and Dextramer R 75N98026Q00782
Summary
AI-generated · Jul 15, 2026Provide custom MHC Class II HLA-DP Xynapse and Dextramer reagents designed for validating liver cancer neoantigens. The procurement focuses on bespoke reagents in Xynapse and Dextramer formats that target the HLA-DP (MHC Class II) pathway to support neoantigen validation studies in liver cancer.
Custom MHC Class II HLA-DP Xynapse and Dextramer Reagents for Liver Cancer Neoantigen Validation
From Solicitation posted on Jul 14, 2026Notice history
1-
Solicitation LATEST Posted Jul 14, 2026
Details
Award Information
Not yet awarded
Contacts
Phone